PatchPrint

PatchPrint is a biotechnology startup dedicated to the development of advanced 3D-printed microneedle patches for painless and efficient drug delivery. Originating as a spin-off from the University of Pittsburgh, the company leverages a proprietary high-resolution 3D printing platform to manufacture customizable microneedle arrays. These patches are designed to deliver vaccines and various therapeutic agents directly through the skin, bypassing the need for traditional needle injections and potentially reducing cold-chain logistics. PatchPrint's technology focuses on improving patient compliance and expanding the reach of life-saving immunizations in both developed and resource-limited settings.